Donald William Cameron

10PUBLICATIONS
30CO-AUTHORS
Medical infection agents (incl. prions)Memory and attentionApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)GlycoconjugatesFood properties (incl. characteristics and health benefits)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 28, 2025
First Use of Phage Therapy in Canada for the Treatment of a Life-Threatening, Multidrug-Resistant <i>Staphylococcus epidermidis</i> Periprosthetic Joint Infection.

Melissa T Cammuso, Bradley W M Cook, D William Cameron

|Aug 28, 2025
Mental Health and Cognitive Outcomes in Patients Six Months After Testing Positive Compared with Matched Patients Testing Negative for COVID-19 in a Non-Hospitalized Sample: A Matched Retrospective Cohort Study.

Brooklyn Ward, Nicole E Edgar, Chloe Ahluwalia

|Nov 16, 2023
Clinical outcomes of immunoglobulin treatment for patients with secondary antibody deficiency: Data from the Ontario immunoglobulin treatment case registry.

Armin Abadeh, Sarah Shehadeh, Stephen Betschel

|Nov 22, 2022
Cutaquig<sup>®</sup> Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products.

Sydney Brownlee, Crystal Allen, Mohammed F Kana'an

|Jul 14, 2022
A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection.

Wendy L Wobeser, Joanne E McBane, Louise Balfour

|Sep 23, 2021
TLR-4 Agonist Induces IFN-γ Production Selectively in Proinflammatory Human M1 Macrophages through the PI3K-mTOR- and JNK-MAPK-Activated p70S6K Pathway.

Niranjala Gajanayaka, Simon Xin Min Dong, Hamza Ali

Pageof 2

Frequent Collaborators

3 joint publications

Juthaporn Cowan

1 joint publications

S Lesperance

1 joint publications

C Pease

1 joint publications

S D Aaron